EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive
Recent news

 

The European Hematology Association’s (EHA) annual congress, one of the most important haematology congresses here in Europe, was held in Vienna, Austria from 9 June to 12 June 2022 in a hybrid format.

Myeloma Patients Europe (MPE) attended EHA 2022 in person and interviewed relevant myeloma and AL amyloidosis specialists to provide an overview of the key highlights in both diseases presented during this meeting.

 

Below you will find videos with the most important updates presented in both diseases:

 

EHAEHA22- CAR-T updates: Interview filmed with Dr Herman Einsele, to summarise the main updates on CAR-T cell therapy presented at the EHA 2022 hybrid congress.

 

 

 

EHA22- AL amyloidosis updates: Interview filmed with Dr Paolo Milani, to summarise the main updates on AL amyloidosis presented at the EHA 2022 hybrid congress.

 

 

 

EHA22- myeloma updates: Interview with Dr Katja Weisel, to summarise the main updates on myeloma presented at the EHA 2022 hybrid congress.

 







Recent news

» Melflufen receives positive opinion from the European Medicines Agency (EMA) for the treatment of refractory myeloma

» European Commission grants conditional approval to CAR-T cell therapy Carvytki (cilta-cel)

Leave a Reply

Your email address will not be published.

I accept the Privacy Policy